Drug-induced cardiotoxicity is a frequent cause of drug attrition during drug development and can lead to the withdrawal of drugs from the market, so non-invasive approaches that allow quick and reliable assessment of the cardiotoxic potential of a compound are key to improve drug safety.
In this application note, learn how the Opera Phenix® Plus high-content screening system together with the MuviCyte™ live-cell imaging system can be used for: